1-20 of 55
Rebecca L. King
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cumulative Incidence, Predictors, and Outcomes of Transformation to Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Patients with Marginal Zone Lymphoma

Côme Bommier, Brian K. Link, Brianna Gysbers, Matthew J. Maurer, Melissa C. Larson, Arushi Khurana, Yucai Wang, Carrie Thompson, Dai Chihara, Juan Pablo Alderuccio, Jean L. Koff, Izidore S. Lossos, Grzegorz S. Nowakowski, Andrew L. Feldman, Thomas M. Habermann, Rebecca L. King, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1672.
https://doi.org/10.1182/blood-2023-186626
Published: 2023
Journal Articles

Truncating SPEN Mutations Highlight BN2-Subtype DLBCL with Aggressive Biology and Features of Immune Evasion

Janek S. Walker, Kerstin Wenzl, Joseph P. Novak, Michelle Manske, Makayla Serres, Allison M. Bock, Melissa A. Hopper, Jordan Edward Krull, Abigail R. Dropik, Miranda S. Laverty, Vivekananda Sarangi, Matthew J. Maurer, Lisa M. Rimsza, Brian K. Link, Thomas M. Habermann, Rebecca L. King, Stephen M Ansell, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Anne J. Novak
Journal: Blood
Blood (2023) 142 (Supplement 1): 4140.
https://doi.org/10.1182/blood-2023-181974
Published: 2023
Journal Articles

Effects of Antibiotic Eradication Therapy on H. Pylori -Negative Stage IE Gastric MALT Lymphoma ─ Real World Experience

Chonlada Laoruangroj, Thomas M. Habermann, Rebecca L. King, Scott Lester, Carrie Thompson, Yucai Wang, Thomas E. Witzig
Journal: Blood
Blood (2023) 142 (Supplement 1): 5157.
https://doi.org/10.1182/blood-2023-174116
Published: 2023
Journal Articles

Comparing Clinical Characteristics and Outcomes of MYC and BCL6 Double Hit Lymphoma (DHL- BCL6 ) with Other Aggressive B-Cell Lymphomas: Understanding the Impact of New Who and International Consensus Classifications

Arushi Khurana, Raphael Mwangi, James R. Cerhan, Jonathon B. Cohen, Jennifer R. Chapman-Fredricks, Jonathan W. Friedberg, Christopher R. Flowers, Richard Burack, Izidore S. Lossos, Loretta J. Nastoupil, Andrew L. Feldman, Brad S. Kahl, Peter Martin, Grzegorz S. Nowakowski, Brian K. Link, Timothy J. McDonnell, Giorgio Inghirami, Sergei Syrbu, Kiran R. Vij, Matthew J. Maurer, Thomas M. Habermann, Rebecca L. King
Journal: Blood
Blood (2023) 142 (Supplement 1): 67.
https://doi.org/10.1182/blood-2023-190316
Published: 2023
Journal Articles

A First in Human Phase I Trial (LS1681) of Abraxane/Rituximab 160 Nm Nanoparticle (AR160) in Relapsed Refractory B-Cell Lymphomas Including Transformed Follicular Lymphoma: A Final Report

Thomas M. Habermann, Betsy LaPlant, Ivana Micallef, Heidi Diann Finnes, Jill Schimke, Robin Klebig, Nikki Hanley, Rebecca L. King, Thomas E. Witzig, Svetomir Markovic
Journal: Blood
Blood (2023) 142 (Supplement 1): 4471.
https://doi.org/10.1182/blood-2023-175014
Published: 2023
Journal Articles

Genomic profiling for clinical decision making in lymphoid neoplasms

Clinical Trials & Observations
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M. Horwitz, Ari M. Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano A. Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz, Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy B. Cook, Francesco d’Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L. King, Young H. Ko, Ann S. LaCasce, Georg Lenz, José I. Martin-Subero, Miguel A. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martinez, Scott J. Rodig, Andreas Rosenwald, Gilles A. Salles, Jesus San-Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier L. Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott
Journal: Blood
Blood (2022) 140 (21): 2193–2227.
https://doi.org/10.1182/blood.2022015854
Published: 2022
Includes: Supplemental data
Journal Articles

Dose Intensity and Reasons for Dose Alterations in Patients Excluded from Frontline Diffuse Large B-Cell Lymphoma Clinical Trials Based on Eligibility Criteria: A Mayo Clinic Cohort Study

Arushi Khurana, Raphael Mwangi, Rebecca L. King, Thomas M. Habermann, Stephen M. Ansell, James R. Cerhan, Grzegorz S. Nowakowski, Thomas E. Witzig, Matthew J. Maurer
Journal: Blood
Blood (2022) 140 (Supplement 1): 6666–6667.
https://doi.org/10.1182/blood-2022-169575
Published: 2022
Journal Articles

Molecular Landscape of Primary Refractory DLBCL

Allison M. Bock, Kerstin Wenzl, Matthew E. Stokes, Joseph P. Novak, Melissa A. Hopper, Jordan E. Krull, Abigail Dropik, Vivekananda Sarangi, Maria Ortiz, Nicholas Stong, C. Chris Huang, Matthew J. Maurer, Rebecca L. King, Richard Curtis Godby, Umar Farooq, Yucai Wang, Stephen M. Ansell, Thomas M. Habermann, James R. Cerhan, Anita K. Gandhi, Grzegorz (Greg) Nowakowski, Anne J. Novak
Journal: Blood
Blood (2022) 140 (Supplement 1): 9221–9223.
https://doi.org/10.1182/blood-2022-156497
Published: 2022
Journal Articles

IRF4 Shapes the Tumor Microenvironment of Follicular Lymphoma

Patrizia Mondello, Kerstin Wenzl, Zhi-Zhang Yang, Changjin Hong, Jordan E. Krull, Xinyi Tang, Vaishali Bhardwaj, Joseph P. Novak, Hyojin Kim, Prithviraj Mukherjee, Rebecca L. King, Tae Hyun Hwang, Mark J Shlomchik, Anne J. Novak, Stephen M. Ansell
Journal: Blood
Blood (2022) 140 (Supplement 1): 168–169.
https://doi.org/10.1182/blood-2022-157408
Published: 2022
Journal Articles

Characterization of Genetic Findings Underlying Aggressive B-Cell Lymphomas with Atypical Results on MYC Break-Apart Fluorescence in Situ Hybridization (FISH) Analysis

Marie-France Gagnon, Alan R Penheiter, Sarah H Johnson, James B Smadbeck, Dorsay Sadeghian, Faye R Harris, Giannoula Karagouga, Alexa McCune, Nicole L Hoppman, Xinjie Xu, Rhett P. Ketterling, Patricia Greipp, Jess F Peterson, George Vasmatzis, Rebecca L. King, Linda B. Baughn
Journal: Blood
Blood (2022) 140 (Supplement 1): 9272–9273.
https://doi.org/10.1182/blood-2022-158832
Published: 2022
Journal Articles

Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma

Matthew E Stokes, Kerstin Wenzl, C. Chris Huang, Maria Ortiz Estevez, Matthew J. Maurer, Nicholas Stong, Patrick Hagner, Yumi Nakayama, Chih-Chao Hsu, Samuel A Danziger, Fadi Towfic, Rebecca L. King, Joel S. Parker, Brian K. Link, Susan L. Slager, Vivekananda Sarangi, Yan Asmann, Joseph P. Novak, Akshay Sudhindra, Stephen M. Ansell, Thomas M. Habermann, Grzegorz S. Nowakowski, James R. Cerhan, Anne J. Novak, Anita K. Gandhi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3548–3550.
https://doi.org/10.1182/blood-2022-170228
Published: 2022
Journal Articles

Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL

Kerstin Wenzl, Matthew E Stokes, Joseph P. Novak, Sana Khan, Melissa A. Hopper, Jordan E. Krull, Abigail Dropik, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C. Chris Huang, Matthew J. Maurer, Lisa M. Rimsza, Brian K. Link, Susan L. Slager, Yan Asmann, Patrizia Mondello, Ryan D. Morin, Stephen M. Ansell, Thomas M. Habermann, Andrew L. Feldman, Rebecca L. King, Grzegorz S. Nowakowski, James R. Cerhan, Anita K. Gandhi, Anne J. Novak
Journal: Blood
Blood (2022) 140 (Supplement 1): 1742–1744.
https://doi.org/10.1182/blood-2022-159620
Published: 2022
Journal Articles

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elias Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla-Martinez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesus San-Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando Lopez-Guillermo, Maria Victoria Mateos, Elizabeth Macintyre, Ari M. Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A. Pileri, Miguel Piris, Barbara Pro, Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier-Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz
Journal: Blood
Blood (2022) 140 (11): 1229–1253.
https://doi.org/10.1182/blood.2022015851
Published: 2022
Includes: Supplemental data
Journal Articles

PET2 Response Associated with Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Results of Two Independent Prospective Cohorts

Sanjal H Desai, Levi D. Pederson, Betsy Laplant, Raphael Mwangi, Matthew J. Maurer, Jason R. Young, William R. Macon, Rebecca L. King, Yucai Wang, James R. Cerhan, Andrew L. Feldman, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski
Journal: Blood
Blood (2021) 138 (Supplement 1): 2508.
https://doi.org/10.1182/blood-2021-151276
Published: 2021
Journal Articles

Mismatch-Repair Deficiency in Follicular Lymphoma Tumors Is Common and Associated with a Favorable Overall Survival

Jithma P. Abeykoon, Dominick E Nowakowski, Jonas Paludo, Michelle K. Manske, Rebecca L. King, Adam J Wood, Surendra Dasari, Gordon Ruan, Matthew J. Maurer, Xiaosheng Wu, Grzegorz S. Nowakowski, Thomas E. Witzig
Journal: Blood
Blood (2021) 138 (Supplement 1): 3523.
https://doi.org/10.1182/blood-2021-152474
Published: 2021
Journal Articles

Follicular Lymphoma Tumor-Cell Transcriptional Programs Associate with Distinct Somatic Alterations and Tumor-Immune Microenvironments

Jordan E. Krull, Kerstin Wenzl, Michelle K. Manske, Melissa A. Hopper, Melissa C. Larson, Vivekananda Sarangi, Matthew J. Maurer, Zhi-Zhang Yang, Lisa M. Rimsza, Brian K. Link, Thomas M. Habermann, Stephen M. Ansell, Rebecca L. King, James R. Cerhan, Anne J. Novak
Journal: Blood
Blood (2021) 138 (Supplement 1): 1327.
https://doi.org/10.1182/blood-2021-153873
Published: 2021
Journal Articles

Parsaclisib in Combination with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: Preliminary Results of a Phase 1/1b Study

Yucai Wang, Betsy Laplant, Rebecca L. King, Ivana N. Micallef, Stephen M. Ansell, Han W. Tun, Madiha Iqbal, Gita Thanarajasingam, Allison C. Rosenthal, David J. Inwards, Patrick B. Johnston, Luis F. Porrata, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski
Journal: Blood
Blood (2021) 138 (Supplement 1): 1415.
https://doi.org/10.1182/blood-2021-147507
Published: 2021
Journal Articles

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair

Jithma P. Abeykoon, Xiaosheng Wu, Kevin E. Nowakowski, Surendra Dasari, Jonas Paludo, S. John Weroha, Chunling Hu, Xiaonan Hou, Jann N. Sarkaria, Ann C. Mladek, Jessica L. Phillips, Andrew L. Feldman, Aishwarya Ravindran, Rebecca L. King, Justin Boysen, Mary J. Stenson, Ryan M. Carr, Michelle K. Manske, Julian R. Molina, Prashant Kapoor, Sameer A. Parikh, Shaji Kumar, Steven I. Robinson, Jia Yu, Judy C. Boughey, Liewei Wang, Matthew P. Goetz, Fergus J. Couch, Mrinal M. Patnaik, Thomas E. Witzig
Journal: Blood
Blood (2021) 137 (4): 513–523.
https://doi.org/10.1182/blood.2020009013
Published: 2021
Includes: Supplemental data
Journal Articles

Salicylates Potentiate and Broaden CRM1 Inhibitor Anti-Tumor Activity Via S-Phase Arrest and Impaired DNA-Damage Repair

Jithma P. Abeykoon, MD, Xiaosheng Wu, MD, Kevin E. Nowakowski, Surendra Dasari, PhD, Jonas Paludo, MD, S. John Weroha, Chunling Hu, PhD, Jann Sarkaria, Ann Mladek, Jessica Phillips, PhD, Andrew L. Feldman, MD, Aishwarya Ravindran, MBBS, Rebecca L. King, MD, Mary J. Stenson, Michelle Manske, MS, BS, Fergus Couch, Mrinal M. Patnaik, MDMBBS, Thomas E. Witzig, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-138619
Published: 2020
Journal Articles

Lenalidomide/RCHOP (R2CHOP) Produces High Response Rates and Overall Survival in New, Untreated Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma- Results from MC078E

Sanjal H Desai, MD, Betsy Laplant, MS, William R. Macon, MD, Rebecca L. King, MD, Yucai Wang, MDPhD, David J. Inwards, MD, Ivana Micallef, MD, Patrick B. Johnston, Luis F. Porrata, MD, Stephen M. Ansell, MD PhD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 47–48.
https://doi.org/10.1182/blood-2020-141298
Published: 2020